$COPR
Idaho Copper Corp Stock $copr

$copr Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224022274 Filed on June 03, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q2
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$975.0K	$1.768M	$401.2K
YoY Change	143.04%	-57.43%	1223.96%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$975.0K	$1.768M	$401.2K
YoY Change	143.04%	-57.43%	1224.17%
Operating Profit	-$975.0K		-$401.2K
YoY Change	143.04%		1224.17%
Interest Expense	$49.81K	-$121.3K	$107.2K
YoY Change	-53.52%	-64.42%	4.64%
% of Operating Profit
Other Income/Expense, Net	-$69.30K	-$79.88K	-$173.8K
YoY Change	-60.13%	1209.51%
Pretax Income	-$1.044M	-$1.969M	-$575.0K
YoY Change	81.61%	-54.2%	1798.0%
Income Tax
% Of Pretax Income
Net Earnings	-$1.044M	-$1.969M	-$575.0K
YoY Change	81.61%	-54.2%	1798.01%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	248.2M shares		208.8M shares
Diluted Shares Outstanding	224.3M shares		17.96M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.005M	$30.15K	$116.7K
YoY Change	761.04%	-93.01%
Cash & Equivalents	$1.005M	$30.15K	$116.7K
Short-Term Investments
Other Short-Term Assets	$103.8K	$21.62K	$23.68K
YoY Change	338.26%		-97.91%
Inventory
Prepaid Expenses	$103.8K	$21.62K	$23.68K
Receivables
Other Receivables
Total Short-Term Assets	$1.109M	$51.77K	$140.4K
YoY Change	689.76%	-88.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.45K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$100.0K	$100.0K	$100.0K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$140.4K	$100.0K	$100.0K
YoY Change	40.45%	0.0%
TOTAL ASSETS
Total Short-Term Assets	$1.109M	$51.77K	$140.4K
Total Long-Term Assets	$140.4K	$100.0K	$100.0K
Total Assets	$1.249M	$151.8K	$240.4K
YoY Change	419.66%	-71.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$406.0K	$434.5K	$283.4K
YoY Change	43.28%	22.48%
Accrued Expenses	$883.1K	$1.486M	$165.6K
YoY Change	433.25%	1512.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$260.0K
YoY Change
Total Short-Term Liabilities	$1.549M	$1.920M	$449.0K
YoY Change	245.04%	329.7%	212.47%
LONG-TERM LIABILITIES
Long-Term Debt	$2.875M	$3.759M	$3.422M
YoY Change	-15.98%	12.09%
Other Long-Term Liabilities	$1.344M	$533.0K	$1.424M
YoY Change	-5.64%	-60.57%
Total Long-Term Liabilities	$4.219M	$4.292M	$4.846M
YoY Change	-12.94%	-8.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.549M	$1.920M	$449.0K
Total Long-Term Liabilities	$4.219M	$4.292M	$4.846M
Total Liabilities	$5.768M	$6.212M	$5.295M
YoY Change	8.93%	20.58%	3585.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$33.05M	-$31.60M	-$28.46M
YoY Change	16.11%	13.31%	284.82%
Common Stock	$247.0K	$214.6K	$209.3K
YoY Change	18.0%	2.97%	943.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.519M	-$6.061M	-$5.055M
YoY Change
Total Liabilities & Shareholders Equity	$1.249M	$151.8K	$240.4K
YoY Change	419.66%	-71.44%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.044M	-$1.969M	-$575.0K
YoY Change	81.61%	-54.2%	1798.01%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$778.4K	-$253.6K	-$314.7K
YoY Change	147.4%	71.83%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.753M	266.0K
YoY Change		-26.32%
NET CHANGE
Cash From Operating Activities	-$778.4K	-253.6K	-$314.7K
Cash From Investing Activities
Cash From Financing Activities	$1.753M	266.0K
Net Change In Cash	$974.9K	12.43K	-$314.7K
YoY Change	-409.82%	-94.18%
FREE CASH FLOW
Cash From Operating Activities	-$778.4K	-$253.6K	-$314.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	800 W. Main Street
CY2024Q2	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1460
CY2024Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Boise
CY2024Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	ID
CY2024Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	83702
CY2024Q2	dei	City Area Code CityAreaCode	(208)
CY2024Q2	dei	Local Phone Number LocalPhoneNumber	274-9220
CY2024Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	11000	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	129145	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	10500	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	140741	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	401156	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-401156	usd
CY2023Q2	COPR	Amortization Of Debt Instrument Convertible Beneficial Conversion Feature AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature	66679	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	208754327	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	208754327	shares
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	189248	usd
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001263364
CY2024Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2024Q1	us-gaap	Longterm Transition Bond Current LongtermTransitionBondCurrent		usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2024Q2	us-gaap	Revenues Revenues		usd
CY2024Q2	COPR	Amortization Of Debt Instrument Convertible Beneficial Conversion Feature AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature		usd
CY2023Q2	COPR	Amortization Of Debt Discount AmortizationOfDebtDiscount		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024Q2	COPR	Stock Issued During Period Value Stock Options One Exercised StockIssuedDuringPeriodValueStockOptionsOneExercised		usd
CY2024Q2	COPR	Amortization Of Debt Instrument Convertible Beneficial Conversion Feature AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature		usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock		usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2024Q2	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q2	COPR	Conversion Of Convertible Notes Payable ConversionOfConvertibleNotesPayable		usd
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1		shares
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q2	COPR	Deferred Tax Assets Timing Differences DeferredTaxAssetsTimingDifferences		usd
CY2024Q1	COPR	Deferred Tax Assets Timing Differences DeferredTaxAssetsTimingDifferences		usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2024Q2	dei	Document Type DocumentType	10-Q
CY2024Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q2	dei	Document Period End Date DocumentPeriodEndDate	2024-04-30
CY2024Q2	dei	Entity Registrant Name EntityRegistrantName	IDAHO COPPER CORPORATION
CY2024Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q2	dei	Entity File Number EntityFileNumber	333-108715
CY2024Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0221494
CY2024Q2	dei	Security12b Title Security12bTitle	Common
CY2024Q2	dei	Trading Symbol TradingSymbol	COPR
CY2024Q2	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	249854437	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1005010	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30146	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	103775	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	1108785	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	40446	usd
CY2024Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	100000	usd
CY2024Q2	us-gaap	Assets Assets	1249231	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	406013	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	342492	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	40446	usd
CY2024Q2	us-gaap	Longterm Transition Bond Current LongtermTransitionBondCurrent	260000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1549086	usd
CY2024Q2	us-gaap	Long Term Transition Bond LongTermTransitionBond	2875000	usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	623999	usd
CY2024Q2	COPR	Interest Payable Non Current InterestPayableNonCurrent	1343984	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4218984	usd
CY2024Q2	us-gaap	Liabilities Liabilities	5768070	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	162	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	162	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	247017097	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	247017097	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	247017	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28284020	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33049876	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-4518839	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1249231	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	258915	usd
CY2024Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	257500	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	107000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	113700	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	189248	usd
CY2024Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	155599	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	13770	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	974962	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-974962	usd
CY2024Q2	COPR	Amortization Of Debt Discount AmortizationOfDebtDiscount	19490	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	49814	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	107166	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-69304	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-173845	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1044266	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-575001	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	224344801	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	224344801	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4620577	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	140739	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-575001	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-5054839	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-6060609	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-6060609	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1753300	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1048793	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1044266	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-4518839	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-4518839	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1044266	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-575001	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	189248	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	140741	usd
CY2023Q2	COPR	Amortization Of Debt Instrument Convertible Beneficial Conversion Feature AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature	66679	usd
CY2024Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	19490	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	82151	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	23675	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-32347	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-69517	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	133840	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	47000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-37750	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-99120	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-778436	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-314653	usd
CY2024Q2	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	1753300	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1753300	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	974864	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-314653	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30146	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	431374	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1005010	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116721	usd
CY2024Q2	COPR	Conversion Of Convertible Notes Payable ConversionOfConvertibleNotesPayable	1048793	usd
CY2024Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	19521	shares
CY2024Q2	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_802_eus-gaap--NatureOfOperations_zQy4LPCeyJ3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82A_zdxbr2YOKXNi">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements include the financial statements of Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) (referred to herein as “Idaho Copper”). Idaho Copper is hereinafter referred to as the “Company,” “we” and “us.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, the Company consummated the transactions contemplated by the Stock Purchase Agreement dated as of January 31, 2022 (the “Purchase Agreement”), by and among the Company, Crystal Globe Limited, a company incorporated under the laws of British Virgin Islands (the “Seller”), and JHP Holdings, Inc., a Nevada corporation (the “Buyer”), pursuant to which the Buyer purchased <span id="xdx_903_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20220203__20220203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zGbV0OanQZsg" title="Buyer purchased common stock shares">16,644,820</span> shares of common stock of the Company from the Seller.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2023, the Company entered into and consummated the transactions contemplated by a share exchange agreement (the “Share Exchange Agreement”) by and among the Company, International CuMo Mining Corporation, an Idaho corporation (“ICUMO”), and all of the shareholders of ICUMO (collectively, the “ICUMO Shareholders”). Pursuant to the terms of the Share Exchange Agreement (the “RTO”), the ICUMO Shareholders transferred all the issued and outstanding shares of common stock of ICUMO to the Company in exchange for <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230123__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zZu3SsZEo5z9" title="Number of shares issued">182,240,000</span> shares of the Company’s common stock, par value $<span id="xdx_909_eus-gaap--EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_c20230123__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_z3NrnTOm22cl" title="Common stock, par value">0.001</span> per share. As a result of this share exchange (the “Exchange”), ICUMO became a wholly owned subsidiary of the Company. See Note 7. For financial reporting purposes, the acquisition of ICUMO and the change of control in connection with the acquisition represented a “reverse merger” and ICUMO is deemed to be the accounting acquirer in the transaction. ICUMO is the acquirer for financial reporting purposes, and the Company is the acquired company. Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the acquisition are those of ICUMO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continues to be a “smaller reporting company,” as defined under the Exchange Act of 1934, as amended (the “Exchange Act”) following the Exchange, however, as a result of the Exchange, the Company has ceased to be a “shell company” (as such term is defined in Rule 12b-2 under the Exchange Act).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ICUMO Background</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ICUMO is an exploration and development company with mineral right interests in the United States of America. ICUMO was originally incorporated under the laws of Nevada in 2005, as Mosquito Mining Corp. In 2013, the Company was moved to Idaho and the name changed to Idaho CuMo Mining Corporation. In early February 2023 the name was changed to Idaho Copper Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in the process of exploring its mineral rights interests in the United States and at the date of these consolidated financial statements, has not yet determined whether any of its mineral properties contain economically recoverable mineral reserves. Accordingly, the carrying amount of mineral right interests represents cumulative expenditures incurred to date and does not necessarily reflect present or future values. The recovery of these costs is dependent upon the discovery of economically recoverable mineral reserves and the ability of the Company to obtain the necessary financing to complete their exploration and development and to resolve any environmental, regulatory, or other constraints. Uncertainty also exists with respect to the recoverability of the carrying value of certain mineral rights interests. The ability of the Company to realize its investment in resource properties is contingent upon the resolution of the uncertainties and confirmation of the Company’s title to the mineral properties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1005010	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1044266	usd
CY2024Q2	COPR	Working Capital Deficit WorkingCapitalDeficit	440301	usd
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_z4jvLXLSaSFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zhLR7nqBTF0k">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	us-gaap	Cash Cash	0	usd
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	162	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	23	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	23	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	405305	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	247017097	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	247017097	shares
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	22646000	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	6566000	shares
CY2024Q2	us-gaap	Longterm Transition Bond Current And Noncurrent LongtermTransitionBondCurrentAndNoncurrent	3135000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue	0.125
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3385000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	162	shares
CY2023Q1	us-gaap	Share Price SharePrice	0.125
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2027-12-31
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	189248	usd
CY2024Q2	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	568000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	The remaining vesting milestones required to be met are (1) obtaining an updated PEA, (2) an uplist of the Company’s common stock to a national exchange and (3) the successful raising of $5 million or more in new capital. Each of these milestones vest an additional 20% of the options upon being met and were estimated to have a 50% probability of being met as of January 31, 2024. Management reviews the estimate of meeting each probability as well as the related timing at each reporting period.
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2614783	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.15
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1093479	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.23
CY2024Q1	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	100000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y29D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2024Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P13M
CY2024Q2	us-gaap	Longterm Purchase Commitment Period LongtermPurchaseCommitmentPeriod	P3Y
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	43200	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	43200	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2754	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	40446	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	65535	usd
CY2021	us-gaap	Payments For Rent PaymentsForRent	68409	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	65535	usd
CY2021	us-gaap	Payments For Rent PaymentsForRent	68409	usd
CY2024Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	615083	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	751916	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.05	pure
CY2024Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-175461	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-285980	usd
CY2024Q2	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-41776	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-68090	usd
CY2024Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	217237	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	354070	usd
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	615083	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	397846	usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	615083	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	397846	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	615083	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	397846	usd
CY2024Q2	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	Company, the net deferred tax assets for 2023 were fully offset by a 100% valuation allowance.
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	615083	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	397846	usd

Files In Submission

Name	View Source	Status
0001493152-24-022274-index-headers.html	Edgar Link	pending
0001493152-24-022274-index.html	Edgar Link	pending
0001493152-24-022274.txt	Edgar Link	pending
0001493152-24-022274-xbrl.zip	Edgar Link	pending
copr-20240430.xsd	Edgar Link	pending
ex10-15.htm	Edgar Link	pending
ex10-15_001.jpg	Edgar Link	pending
ex10-15_002.jpg	Edgar Link	pending
ex10-15_003.jpg	Edgar Link	pending
ex10-15_004.jpg	Edgar Link	pending
ex10-15_005.jpg	Edgar Link	pending
ex10-15_006.jpg	Edgar Link	pending
ex10-15_007.jpg	Edgar Link	pending
ex10-15_008.jpg	Edgar Link	pending
ex10-15_009.jpg	Edgar Link	pending
ex10-15_010.jpg	Edgar Link	pending
ex10-15_011.jpg	Edgar Link	pending
ex10-15_012.jpg	Edgar Link	pending
ex10-15_013.jpg	Edgar Link	pending
ex10-15_014.jpg	Edgar Link	pending
ex10-15_015.jpg	Edgar Link	pending
ex10-15_016.jpg	Edgar Link	pending
ex10-15_017.jpg	Edgar Link	pending
ex10-15_018.jpg	Edgar Link	pending
ex10-15_019.jpg	Edgar Link	pending
ex10-15_020.jpg	Edgar Link	pending
ex10-15_021.jpg	Edgar Link	pending
ex10-15_022.jpg	Edgar Link	pending
ex10-15_023.jpg	Edgar Link	pending
ex10-15_024.jpg	Edgar Link	pending
ex10-15_025.jpg	Edgar Link	pending
ex10-15_026.jpg	Edgar Link	pending
copr-20240430_cal.xml	Edgar Link	unprocessable
copr-20240430_def.xml	Edgar Link	unprocessable
copr-20240430_pre.xml	Edgar Link	unprocessable
copr-20240430_lab.xml	Edgar Link	unprocessable
ex10-15_027.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COPR
Idaho Copper Corp Stock $copr

2024 Q2 Form 10-Q Financial Statement

#000149315224022274 Filed on June 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COPR Idaho Copper Corp Stock $copr

2024 Q2 Form 10-Q Financial Statement

#000149315224022274 Filed on June 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COPR
Idaho Copper Corp Stock $copr